In recent years, scientists have made several breakthroughs in the research about cancer chemotherapy. Here, we sort out the studies about cancer chemotherapy. 1.Modular gene enhancer promotes leukemia and regulates […]
A total of seven new small molecule kinase inhibitors have been approved by FDA in 2017. Protein kinases form a very large family of signaling proteins, with more than 500 […]
Angiotensin-converting enzyme (ACE) is a dipeptidyl caboxy peptidase, located in many tissues and biological fluids, that plays a key role in the regulation of blood pressure and normal cardiovascular functions. The […]
Caffeine, a xanthine alkaloid compound, is a central nervous system stimulant that effectively drowsiness and helps regain energy and is clinically used to treat neurasthenia and coma. In recent years, […]
Obesity is a major global health issue, affecting all age groups. Obesity increases the risk of several serious human diseases, including cardiovascular disease, type 2 diabetes and cancer. Despite this […]
Parkinson’s disease is a common degenerative disease of the nervous system in the elderly, which can seriously affect the quality of life of patients and put great pressure on patients […]
Metformin has proven to be a “magic drug” beyond its application in treating diabetes. Over the past 20 years, metformin has become the mainstay of type 2 diabetes treatment and […]
The top spot in the world’s best-selling drug list may not be a suspense in the short term, according to a report by EvaluatePharma, a market research firm. In 2018, […]
Olaparib, also known as AZD-2281 or KU-59436, is a small molecule inhibitor of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to […]
December 7, 2017 – Researchers from Brock University have found that certain amounts of lithium in drinking water may slow death rates in people with Alzheimer’s disease, according to a […]